CTDP1 and UPP1

Number of citations of the paper that reports this interaction (PubMedID 12036313)
6

Data Source:
BioGRID (enzymatic study)

		CTDP1	UPP1
Description		CTD phosphatase subunit 1	uridine phosphorylase 1
Image
GO Annotations	Cellular Component	Spindle Pole Nucleus Nucleoplasm Cytoplasm Centrosome Spindle Midbody Protein-containing Complex Intracellular Membrane-bounded Organelle Spindle Midzone	Nucleoplasm Cytosol
	Molecular Function	TFIIF-class Transcription Factor Complex Binding Phosphoprotein Phosphatase Activity Protein Binding RNA Polymerase II CTD Heptapeptide Repeat Phosphatase Activity Tat Protein Binding	Uridine Phosphorylase Activity
	Biological Process	Transcription By RNA Polymerase II Transcription Elongation From RNA Polymerase II Promoter Protein Dephosphorylation Exit From Mitosis Positive Regulation By Host Of Viral Transcription Positive Regulation Of Viral Transcription Cell Division Negative Regulation Of Cell Growth Involved In Cardiac Muscle Cell Development Dephosphorylation Of RNA Polymerase II C-terminal Domain	Nucleobase-containing Compound Metabolic Process Uridine Catabolic Process Nucleotide Catabolic Process Cellular Response To Glucose Starvation Pyrimidine Nucleoside Salvage UMP Salvage Pyrimidine Nucleoside Catabolic Process
Pathways		Formation of RNA Pol II elongation complex Formation of the Early Elongation Complex Formation of HIV elongation complex in the absence of HIV Tat Formation of the HIV-1 Early Elongation Complex Formation of HIV-1 elongation complex containing HIV-1 Tat Formation of HIV-1 elongation complex containing HIV-1 Tat Pausing and recovery of Tat-mediated HIV elongation Abortive elongation of HIV-1 transcript in the absence of Tat Tat-mediated HIV elongation arrest and recovery Tat-mediated elongation of the HIV-1 transcript HIV elongation arrest and recovery Pausing and recovery of HIV elongation RNA Polymerase II Pre-transcription Events TP53 Regulates Transcription of DNA Repair Genes RNA Polymerase II Transcription Elongation	Pyrimidine salvage Pyrimidine catabolism
Drugs			RP101 1-((2-HYDROXYETHOXY)METHYL)-5-BENZYLPYRIMIDINE-2,4(1H,3H)-DIONE
Diseases
GWAS		Adverse response to drug ( 30420678) Cerebrospinal P-tau181p levels ( 28247064) Metabolite levels ( 23823483) Monocyte count ( 27863252) Schizophrenia ( 23212062) Smoking initiation (ever regular vs never regular) ( 30679032)	Metabolite levels ( 23823483)
Interacting Genes		40 interacting genes: CDK7 CDK8 CDK9 CSNK2A1 CSNK2A2 CSNK2B E2F1 ELP2 ELP3 ERH GTF2F1 INTS1 INTS3 INTS6 INTS7 INTS8 MED1 MED14 MED15 MED16 MED17 MED23 MED24 MED25 MED26 MED4 MED6 MED7 MED8 NDRG2 POLR2A POLR2B PRKDC PRMT5 SNRNP70 SNRPB STK38 TCEA1 UPP1 WDR77	2 interacting genes: CTDP1 VIM
Entrez ID		9150	7378
HPRD ID		05377	08932
Ensembl ID		ENSG00000060069	ENSG00000183696
Uniprot IDs		A0A0A0MR03 Q9Y5B0	B4DND0 Q16831 Q86Y75
PDB IDs		1J2X 1ONV 2K7L	3EUE 3EUF 3NBQ
Enriched GO Terms of Interacting Partners?
Tagcloud ?
Tagcloud (Difference) ?
Tagcloud (Intersection) ?